Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Class A Common Stock, $0.00001 par value per share
-
Shares outstanding
-
4,564,846
-
Total 13F shares
-
943,059
-
Share change
-
-1,723,065
-
Total reported value
-
$3,881,243
-
Price per share
-
$4.09
-
Number of holders
-
40
-
Value change
-
-$8,350,655
-
Number of buys
-
16
-
Number of sells
-
16
Institutional Holders of RECURSION PHARMACEUTICALS, INC. - Class A Common Stock, $0.00001 par value per share (RXRX) as of Q4 2025
As of 31 Dec 2025,
RECURSION PHARMACEUTICALS, INC. - Class A Common Stock, $0.00001 par value per share (RXRX) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
943,059 shares.
The largest 10 holders included
Green Alpha Advisors, LLC, Stratos Wealth Partners, LTD., 180 WEALTH ADVISORS, LLC, SG Americas Securities, LLC, KIECKHEFER GROUP LLC, Sowell Financial Services LLC, Cherry Creek Investment Advisors, Inc., Accel Wealth Management, Clarius Group, LLC, and Prime Capital Investment Advisors, LLC.
This page lists
40
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.